Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Seval Orman
Observed names:
Orman, Seval,
Seval ORMAN
Institutions:
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
ORCID:
0009-0008-6771-3263
Observed ORCID:
0009-0008-6771-3263
OpenAlex ID:
A5049867018
The Role of Ultrasonic Cardiac Output Monitor in Evaluating Stroke Volume Variation to Determine Fluid Responsiveness in Patients With Shock
2025
·
Seval Orman
, Pervin Hancı
, et al.
·
Shock
·
26
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025
·
Nadiye Sever
, Fatih Şimşek
, et al.
·
Journal of Clinical Medicine
·
19
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study
2024
·
Salih Tünbekici
, Haydar cagatay Yuksel
, et al.
·
Cancers
·
13
PDF
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group
2024
·
Arif Akyildiz
, Melis Gultekin
, et al.
·
International Journal of Gynecological Cancer
·
6
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
2025
·
Zehra Sucuoğlu İşleyen
, Seval Ay
, et al.
·
Scientific Reports
·
2
PDF
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study
2025
·
Seval Orman
, Miray Aydoğan
, et al.
·
Medicina
·
2
PDF
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer
2025
·
Ezgi Turkoglu
, Goncagul Akdag Topal
, et al.
·
Breast Cancer Research and Treatment
·
2
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2− Metastatic Breast Cancer: A Real-World Cohort Study
2026
·
Seval Orman
, Miray Aydoğan
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes
2026
·
Sedat Yildirim
, Hatice Odabas
, et al.
·
Journal of Clinical Medicine
·
1
PDF
The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG).
2024
·
Arif Akyildiz
, Melis Gultekin
, et al.
·
Journal of Clinical Oncology
·
1
Association Between Metastatic Patterns and Overall Survival in Metastatic Gastric Cancer: A Single-Centre Real-World Study
2026
·
Seval Orman
, Hamit Bal
, et al.
·
The European Research Journal
PDF
Outcomes of CDK4 /6 Inhibitor‐Based Therapy in Premenopausal HR +/ HER2 − Metastatic Breast Cancer: Real World Data From A Multicenter Study
2026
·
Hatice Odabaş
, Omar Alomari
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis
2026
·
Halil Göksel Güzel
, Derya Kıvrak Salim
, et al.
·
The Oncologist
Efficacy of Palbociclib and Ribociclib in Second-line Treatment of Metastatic Hormone Receptor-positive Breast Cancer: A Single-center Experience
2025
·
Sedat YILDIRIM
, Özlem Nuray SEVER
, et al.
·
Journal of Oncological Sciences
PDF
Kanserde Takip
2025
·
Şermin Dinç Sonuşen
, İbrahim Bilen
, et al.
·
Akademisyen Kitabevi eBooks
PDF
Akciğer Nöroendokrin Tümörleri
2025
·
Seval Orman
·
Akademisyen Kitabevi eBooks
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
2024
·
Ayşegül Sakin
, Kubilay Karaboyun
, et al.
·
Akademisyen Kitabevi eBooks
PDF
Ada Çayı (Salvia Officinalis)
2024
·
Seval Orman
·
Akademisyen Kitabevi eBooks
Show more works
View as search
Works count:
19
Citation count:
72
H-index:
4
I10-index:
3
Year
Topic
Type